» Articles » PMID: 15677465

Fibronectin Regulates Latent Transforming Growth Factor-beta (TGF Beta) by Controlling Matrix Assembly of Latent TGF Beta-binding Protein-1

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2005 Jan 29
PMID 15677465
Citations 167
Authors
Affiliations
Soon will be listed here.
Abstract

Latent transforming growth factor-beta-binding proteins (LTBPs) are extracellular matrix (ECM) glycoproteins that play a major role in the storage of latent TGF beta in the ECM and regulate its availability. Here we show that fibronectin is critical for the incorporation of LTBP1 and transforming growth factor-beta (TGF beta) into the ECM of osteoblasts and fibroblasts. Immunolocalization studies suggested that fibronectin provides an initial scaffold that precedes and patterns LTBP1 deposition but that LTBP1 and fibronectin are later localized in separate fibrillar networks, suggesting that the initial template is lost. Treatment of fetal rat calvarial osteoblasts with a 70-kDa N-terminal fibronectin fragment that inhibits fibronectin assembly impaired incorporation of LTBP1 and TGFbeta into the ECM. Consistent with this, LTBP1 failed to assemble in embryonic fibroblasts that lack the gene for fibronectin. LTBP1 assembly was rescued by full-length fibronectin and superfibronectin, which are capable of assembly into fibronectin fibrils, but not by other fibronectin fragments, including a 160-kDa RGD-containing fragment that activates alpha5beta1 integrins. This suggests that the critical event for LTBP1 assembly is the formation of a fibronectin fibrillar network and that integrin ligation by fibronectin molecules alone is not sufficient. Not only was fibronectin essential for the initial incorporation of LTBP1 into the ECM, but the continued presence of fibronectin was required for the continued assembly of LTBP1. These studies highlight a nonredundant role for fibronectin in LTBP1 assembly into the ECM and suggest a novel role for fibronectin in regulation of TGF beta via LTBP1 interactions.

Citing Articles

Mechanical forces in the tumor microenvironment: roles, pathways, and therapeutic approaches.

Zhang Y, Fu Q, Sun W, Yue Q, He P, Niu D J Transl Med. 2025; 23(1):313.

PMID: 40075523 PMC: 11899831. DOI: 10.1186/s12967-025-06306-8.


Mutations in fibronectin dysregulate chondrogenesis in skeletal dysplasia.

Dinesh N, Rousseau J, Mosher D, Strauss M, Mui J, Campeau P Cell Mol Life Sci. 2024; 81(1):419.

PMID: 39367925 PMC: 11456097. DOI: 10.1007/s00018-024-05444-4.


Role of integrins in the development of fibrosis in the trabecular meshwork.

Faralli J, Filla M, Peters D Front Ophthalmol (Lausanne). 2024; 3:1274797.

PMID: 38983065 PMC: 11182094. DOI: 10.3389/fopht.2023.1274797.


Uncovering a Novel Functional Interaction Between Adult Hepatic Progenitor Cells, Inflammation and EGFR Signaling During Bile Acids-Induced Injury.

Garcia-Saez J, Figueroa-Fuentes M, Gonzalez-Corralejo C, Roncero C, Lazcanoiturburu N, Gutierrez-Uzquiza A Int J Biol Sci. 2024; 20(7):2339-2355.

PMID: 38725853 PMC: 11077361. DOI: 10.7150/ijbs.90645.


Delivery technologies for therapeutic targeting of fibronectin in autoimmunity and fibrosis applications.

Bonadio J, Bashiri G, Halligan P, Kegel M, Ahmed F, Wang K Adv Drug Deliv Rev. 2024; 209:115303.

PMID: 38588958 PMC: 11111362. DOI: 10.1016/j.addr.2024.115303.